A privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, and others. They have offices in Ann Arbor, Michigan and Minneapolis, MN.
PRODUCTS: A sophisticated platform that delivers pulsed sound energy into the body, without any incisions or needles, and has the ability to destroy tumors at the sub-cellular level, all while the treating physician continuously monitors the "bubble cloud" and treatment effect in real-time.
Delivering continuous visualization, personalized treatment and physician control.
Base: 250K VARIABLE COMP 250K total comp-500K at plan, uncapped, equity, car allowance, plus gas, Full expenses, 401K, medical/dental, 401K, etc, top reps make 500K plus